AMERIPRISE FINANCIAL INC
Position in MRVI — Maravai Lifesciences Holdings, Inc.
CIK 820027
MINNEAPOLIS, MN
Position in MRVI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$242,080
+$197,786 QoQ
Shares Held
85,541
+527.6% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
19 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 99.98480260927508.ToString("F0")%
None 0.015197390724915537.ToString("F0")%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AMERIPRISE FINANCIAL INC holds $4,230,069,783 across 189 Biotechnology names. MRVI ranks #171 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,633,481 | $1,175,954,602 | |
| 2 | INSM |
INSMED Inc
|
3,057,718 | $499,998,043 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,608,476 | $304,082,386 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
319,677 | $246,995,233 | |
| 5 | ARGX |
Argenx SE
|
215,910 | $157,668,275 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,579,793 | $153,634,868 | |
| 7 | ASND |
Ascendis Pharma A/S
|
476,466 | $108,982,067 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,248,521 | $92,715,166 |
All Filings in MRVI
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $242,080 | 85,541 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $44,294 | 13,629 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,611,739 | 1,606,878 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,912,642 | 1,623,503 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,443,994 | 2,463,346 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $19,683,355 | 3,611,625 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $29,496,360 | 3,549,502 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $21,441,835 | 2,994,670 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $26,041,948 | 3,003,685 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $14,289,589 | 2,181,617 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $21,863,880 | 2,186,388 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $20,820,260 | 1,675,001 | Shares | Defined | 2023-08-14 | |
| 2022-06-30 | $1,533,997 | 53,995 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,637,959 | 103,146 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $382,127 | 9,120 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $18,766,129 | 382,358 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $24,370,569 | 584,006 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $913,666 | 25,636 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $622,092 | 22,178 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||